Package 68788-8482-9

{"route": ["ORAL"], "spl_id": "73082b8a-c692-4014-8bb1-21529579e047", "openfda": {"unii": ["G447S0T1VC"], "rxcui": ["313565"], "spl_set_id": ["9eff97fa-095c-483c-a4eb-e46e5fef7785"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-8482-3)", "package_ndc": "68788-8482-3", "marketing_start_date": "20230714"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (68788-8482-9)", "package_ndc": "68788-8482-9", "marketing_start_date": "20230714"}], "brand_name": "Valacyclovir Hydrochloride", "product_id": "68788-8482_73082b8a-c692-4014-8bb1-21529579e047", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68788-8482", "generic_name": "valacyclovir", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valacyclovir Hydrochloride", "active_ingredients": [{"name": "VALACYCLOVIR HYDROCHLORIDE", "strength": "500 mg/1"}], "application_number": "ANDA078518", "marketing_category": "ANDA", "marketing_start_date": "20230714", "listing_expiration_date": "20261231"}